Details for New Drug Application (NDA): 088337
✉ Email this page to a colleague
NDA 088337 describes ERGOSTAT, which is a drug marketed by Watson Labs Inc and is included in one NDA. Additional details are available on the ERGOSTAT profile page.
The generic ingredient in ERGOSTAT is ergotamine tartrate. There are thirteen drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the ergotamine tartrate profile page.
The generic ingredient in ERGOSTAT is ergotamine tartrate. There are thirteen drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the ergotamine tartrate profile page.
Summary for 088337
| Tradename: | ERGOSTAT |
| Applicant: | Watson Labs Inc |
| Ingredient: | ergotamine tartrate |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 088337
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;SUBLINGUAL | Strength | 2MG | ||||
| Approval Date: | Jun 8, 1984 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
